Steroid 21-hydroxylase autoantibodies: Measurements with a new immunoprecipitation assay

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1440-1446

  Tanaka, Hideaki ^a,c   Perez, Maria S ^a,c   Powell, Michael ^a   Sanders, Jane F ^a   Sawicka, Joanna ^a,c   Chen, Shu ^a,c   Prentice, Louise ^a   Asawa, Takayuki ^a,c   Betterle, Corrado ^b   Volpato, Marina ^b   Smith, Bernard Rees ^a,c   Furmaniak, Jadwiga ^a,c  

^a RSR LTD   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IODINE 125; STEROID 21 MONOOXYGENASE;

ACCURACY; ADDISON DISEASE; ADOLESCENT; ADRENAL DISEASE; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIAGNOSIS; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; MYASTHENIA GRAVIS; OVARY DISEASE; PRIORITY JOURNAL;

EID: 8244262431     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1440     Document Type: Article

References (41)

1. Muir A, Schatz DA, Maclaren NK. 1993 Autoimmune Addison's disease. Springer Semin Immunopathol. 14:275-284.
2. Rees Smith B, Furmaniak J. 1995 Editorial: adrenal and gonadal autoimmune diseases. J Clin Endocrinol Metab. 80:1502-1505.
3. Betterle C, Volpato M, Greggio AN, Presotto F. 1996 Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab. 9:113-123.
4. Chen S, Sawicka J, Betterle C, et al. 1996 Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease and premature ovarian failure. J Clin Endocrinol Metab. 81:1871-1876.
5. Bednarek J, Furmaniak J, Wedlock N, et al. 1992 Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett. 309:51-55.
6. Colls J, Betterle C, Volpato M, Prentice L, Rees Smith B, Furmaniak J. 1995 Immunoprecipitation assay tor autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin Chem. 41:375-380.
7. Beever K, Bradbury J, Phillips D, et al. 1989 Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem. 35:1949-1954.
8. Southgate K, Creagh FM, Teece M, Kingswood C, Rees Smith B. 1984 A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol (Oxf). 20:539-543.
9. 125I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta. 256:175-188.
10. Vincent A, Newsom Davis J. 1985 Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychol. 48:1246-1252.
11. Asawa T, Wedlock N, Baumann-Antczak A, Rees Smith B, Furmaniak J. 1994 Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. J Clin Endocrinol Metab. 79:372-376.
12. Schuller HJ, Entian KD. 1988 Molecular characterization of yeast regulatory gene CAT3 necessary for glucose depression and nuclear localization of its product. Gene. 67:247-257.
13. Ito H, Jukuda Y, Murata K, Kimura A. 1983 Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 153:163-168.
14. Kominami S, Ochi H, Kobayashi Y, Takemori S. 1980 Studies on the steroid hydroxylation system in adrenal cortex microsomes. J Biol Chem. 255:3386-3394.
15. scc. J Biol Chem. 257:12696-12704.
16. 4. Nature. 227:680-684.
17. Bradford MM. 1976 Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254.
18. 131I-labelled human growth hormone of high specific radioactivity. Biochem J. 89:114-123.
19. Wedlock N, Asawa T, Baumann-Antczak A, Rees Smith B, Furmaniak J. 1993 Autoimmune Addison's disease: analysis of autoantibody binding sites on human steroid 21-hydroxylase. FEBS Lett. 332:123-126.
20. Birk HW, Koepsell H. 1987 Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic sites and reduction of non-specific antibody binding. Anal Biochem. 164:12-22.
21. Smith DB, Corcoran LM. 1994 Expression and purification of glutathione-S-transferase fusion proteins. Curr Protocols Mol Biol. 2:16.7.1-16.7.7.
22. Betterle C, Volpato M, Pedini B, Boscaro M, Tedesco F, Presotto F. 1994 The natural history of Addison's disease in organ-specific autoimmune patients with adrenal cortex antibodies. Immunological study. In: Besser GM, Bhatt Q, Boltazzo GF, Fallo F, James VHT, Keen H, eds. Advances in Thomas Addison's diseases. Bristol: Journal of Endocrinology and the Thomas Addison Society. 51-58.
23. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. 1993 Two different cytochrome p450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest. 92:2377-2385.
24. Song Y-H, Connor EL, Muir A, et al. 1994 Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J Clin Endocrinol Metab. 78:1108-1112.
25. Falorni A, Nikoshkov A, Laureti S, et al. 1995 High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 80:2752-2755.
26. Uibo R, Aavik E, Peterson P, et al. 1994 Autoantibodies to cytochrome p450 enzymes p450scc, p450c17, and p40c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab. 78:323-328.
27. 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 43:454-467.
28. Vandewalle CL, Falorni A, Svanholm S, et al. 1995 High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab. 80:846-851.
29. Nerup J. 1974 Addison's disease-serological studies. Acta Endocrinol (Copenh). 76:142-158.
30. Riley WJ, Maclaren NK, Neufeld M. 1980 Adrenal autoantibodies and Addison disease in insulin-dependent diabetes mellitus. J Pediatr. 97:191-195.
31. Scherbaum WA, Berg PA. 1982 Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex. Clin Endocrinol (Oxf). 16:345-352.
32. De Bellis A, Bizzarro A, Rossi R, et al. 1993 Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab. 76:1002-1007.
33. Betterle C, Volpato M, Rees Smith B, et al. 1997 I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab. 82:932-938.
34. Blizzard RM, Kyle M. 1963 Studies of the adrenal antigens and antibodies in Addison's disease. J Clin Invest. 42:1653-1660.
35. Ahonen P, Miettinen A, Perheentupa J. 1987 Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab. 64:494-500.
36. Betterle C, Volpato M, Rees Smith B, et al. 1997 II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab. 82:939-942.
37. Boulton R, Hamilton MI, Dhillon AP, Kinloch JD, Burroughs AK. 1995 Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values. Gastroenterology. 109:1324-1327.
38. Keljo DJ, Squires RH. 1996 Clinical problem-solving. Just in time. N Engl J Med. 334:46-48.
39. Brosnan CM, Gowing NFC. 1996 Addison's disease. Br Med J. 312:1085-1087.
40. Soest R, Mullerlissner S. 1996 Clinical manifestation of adrenal cortical insufficiency during thyroid hormone substitution. Dtsch Med Wochenschr. 121:406-4118.
41. Armstrong L, Bell PM. 1996 Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. Br Med J. 312:1601-1602.